Regeneron Pharmaceuticals Inc (REGN) Faces Trouble With Eylea Amid Strong Sales
Eylea has been one of the main drivers of growth for Regeneron over the past couple of years.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
News
- First
- << Previous
- 171 - 180
- Next >>
Why Investors Are Watching Dean Foods, Regeneron Pharmaceuticals, Halliburton, and More
It's another quiet day on the Street as the main indexes are moderately in the green while the VIX is down 3% to trade below 15.
10 Most Successful Innovative Companies in The World in 2016
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have already been brought to...
Here's Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday
In this article, we will analyze the latest events surrounding Amazon.com, Inc.
Why RBS, Cheniere Energy, Regeneron Pharmaceuticals & Two Other Stocks Are in Spotlight Today
The major indexes opened higher on the last trading day of the quarter as some investors remain on the sidelines due to the Deutsche Bank uncertainty.
Healthcare Investor Sam Isaly Was Wrong About These 2 Stocks; Makes a Lot of Money on Freshly-Acquired Insurer
OrbiMed Advisors LLC is the world’s largest healthcare-focused investment firm, managing roughly $15 billion in net assets under management.
Hedge Funds Are Betting On Regeneron Pharmaceuticals Inc (REGN)
The market has been volatile as the Federal Reserve winds down its easy money policies.
Sivik Global Healthcare's Top Biotech Stock Picks For Q4
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006.
Highlights From Viking Global's Investor Letter: Alibaba Group Holding Ltd (BABA), Regeneron Pharmaceuticals Inc (REGN)
We have seen a copy of Viking Global's third quarter investor letter. Andreas Halvorsen's Viking Global is among the most successful long/short equity hedge funds (Stock Picks, Investor Letters).
Regeneron Pharmaceuticals Inc (REGN) Calls Game, Set and Match On Its Competitor: Jim Cramer
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially those with a speculative itch.
- First
- << Previous
- 171 - 180
- Next >>
Billionaire Hedge Funds
